Medipixel
About Medipixel
Medipixel is a global healthcare AI company that develops diagnostic and therapeutic solutions for interventional procedures, primarily focusing on cardiovascular diseases. The company leverages artificial intelligence and robotics technology to create products that provide faster and more accurate real-time analysis. Their core offerings include AI-powered software for quantitative coronary analysis (QCA) and functional assessment, aiming to revolutionize diagnostic and treatment protocols in interventional cardiology.
Medipixel’s solutions, such as MPXA and MPFFR, are designed to integrate into the cath lab workflow, assisting physicians in real-time during procedures like stent placements. The company has received regulatory approvals for its products, including KFDA approval in 2021 and U.S. FDA 510(k) certification in May 2023 for MPXA-2000. Medipixel is also expanding its service offerings to encompass diverse fields, including neurovascular care with products like MPNeuro.
Focus Areas
Business Intelligence
| Technology | AI-powered platform for coronary angiography analysis and functional assessment, deep learning technology, computer vision, reinforcement learning, cloud-native |
What Physicians Need to Know
Medipixel's solutions, MPXA and MPFFR, offer significant advantages for physicians in interventional cardiology. MPXA provides rapid, automated, and highly accurate quantitative analysis of coronary angiography images, including stenosis percentage and optimal stent recommendations, in real-time. This can streamline workflow in the cath lab and assist in making faster, more objective, and reproducible treatment decisions. MPFFR offers a non-invasive method for functional diagnosis (FFR) directly from angiography images, reducing the need for invasive pressure wires and associated time and cost burdens. This allows for simultaneous assessment of anatomical stenosis and functional ischemia, supporting more precise treatment strategies. The automated nature of their software minimizes manual intervention, enhancing efficiency and accuracy. Medipixel's commitment to clinical validation, with ongoing multicenter trials and published studies, further supports the reliability and clinical value of their AI-based tools.
Medipixel's AI solutions are designed to integrate into existing cath lab workflows, providing real-time analysis of DICOM contrast images uploaded during cardiovascular imaging. Their systems aim to support cardiologists and cath lab staff with PCI procedural assistance and research functionalities. The company is also working towards global market expansion, having secured various international certifications and patents.
What the Web Says
Medipixel is a South Korean AI-powered medical device company specializing in cardiovascular imaging analysis and expanding into neurovascular solutions. The company has received significant recognition in the healthcare technology industry, including being named to TIME's "World's Top 400 HealthTech Companies 2025" and Newsweek's "World's Best Digital Health Companies 2024 (Diagnostics)". Their core product, MPXA-2000, uses AI to quantify coronary artery stenotic lesions from 2D angiography images, offering a less invasive alternative to intravascular ultrasound (IVUS).
Overall: PositiveStrengths
- AI-powered solutions for cardiovascular and neurovascular imaging analysis.
- MPXA-2000 provides validated, reproducible quantitative results for diagnosis and treatment evaluation of coronary artery disease.
- Less invasive alternative to traditional methods like IVUS for coronary artery analysis.
- Strong industry recognition and awards.
- Global market expansion with certifications in various countries.
- Focus on technological innovation and clinical applicability.
Limitations
- Limited public product reviews available on major platforms like G2, Capterra, and Glassdoor.
- One expert noted a moderate to strong correlation for MPXA-2000's results, with some correlation coefficients being described as less robust by an AI.
- No readily available employer reviews on Glassdoor or similar platforms were found in the search results.
- No specific product or employer reviews found on Reddit directly for Medipixel.
Based on reviews from: RadAISlice, Tarek Roustom, MD (via Medium), TIME, Medipixel, Inc. (History section), MedTech Innovator, HealthTech Alpha, Korea Biomedical Review, Innolitics
Last updated: 2026-10-20
Videos
News, demos, and interviews about Medipixel.
Videos load interactively. If none appear, search YouTube for Medipixel →
Press & Coverage
Frequently Asked Questions
Related Companies
Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]
Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]
Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]
Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]
HeartLung.AI is a health-tech company focused on leveraging artificial intelligence for the early detection and prevention of cardiovascular disease and lung cancer. Their mission is to shift healthcare from late-stage disease treatment to earlier identification and prevention by unlocking clinically actionable information embedded within routine medical imaging. The company has developed several FDA-cleared and breakthrough-designated […]
Heartvue.ai is a healthcare AI company focused on transforming cardiovascular imaging analysis. Founded by a cardiologist with over two decades of experience in advanced cardiac imaging, the company develops AI-powered tools to make advanced cardiac imaging analysis more accessible, consistent, and efficient for healthcare systems. Their mission is to alleviate the burden of manual workflows […]